|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Reconciliation of net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation of fixed assets and leases | |||||
| Write down of fixed assets | |||||
| Provision for write down of inventory | |||||
| Provision for bad debt expense | |||||
| Issuance of stock to consultant | |||||
| Stock based compensation | |||||
| Amortization of debt costs and debt discount | |||||
| Amortization of intangibles | |||||
| Non cash lease expense | |||||
| Right-of-use asset lease expense | |||||
| Deferred income taxes | |||||
| Foreign currency exchange (gain) loss | |||||
| Partial extinguishment of 3.75% senior notes | |||||
| Extinguishment of prior term loan | |||||
| Non cash interest expense | |||||
| Impairment of long-lived assets | |||||
| (Gain)/loss on debt restructuring | |||||
| Inducement loss | |||||
| Change in the fair value of derivative liability | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories, net | |||||
| Prepaid expenses and other current receivables | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Operating liabilities | |||||
| Deferred income | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Disposal of fixed assets | |||||
| Product acquisition costs, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from term loan | |||||
| 2021 Term Loan | |||||
| 2023 Term Loan | |||||
| Proceeds from term loan | |||||
| 2021 Term Loan | |||||
| 2023 Term Loan | |||||
| Total proceeds from term loan | |||||
| Proceeds from senior notes | |||||
| Derivative liabilities related to Series B Convertible Notes | |||||
| 2023 Series C Convertible Notes | |||||
| Total proceeds from senior notes | |||||
| Proceeds from 2023 Series B bifurcated conversion option | |||||
| Proceeds from revolver | |||||
| Repayment of 2021 term loan, net | |||||
| Repayment of revolver | |||||
| Repayment of prior term loan, net | |||||
| Repayment of 3.75% senior notes | |||||
| Debt issuance costs | |||||
| Repurchase of 3.75% senior notes | |||||
| Proceeds from exercise of common stock options and warrants | |||||
| Principal payments on capital lease obligations | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Payment (recovery) from stockholder, net | |||||
| Government grant advance | |||||
| Principal payments on financing lease obligations | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate on cash, cash equivalents and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental Cash flow information: | |||||
| Cash payments for interest | |||||
| Cash payments for income taxes | |||||
| Non cash investing and financing transactions: | |||||
| Acquisition of capital expenditures in accounts payable and accrued expenses | |||||
| Capitalized stock compensation in capital expenditures | |||||
| Issuance of stock to consultant | |||||
| Bifurcation of derivative from convertible 3.75% senior notes | |||||
| Other Noncash Income | |||||
Loading...